Non invasive Atrial Fibrillation treatment on your wrist

Weathering the atrial fibrillation storm

Atrial Fibrillation Data

  • 7 Million

    Diagnosed in the US

  • 1 in 4

    Adults ages 40+

  • 40-50%

    Suffer from poor response to therapy

  • At risk

    X5 risk of stroke X4 risk of heart of failure

Physician & Patient Testimonials

"After 12 years of controlling my atrial fibrillation, my medication stopped being effective ... I underwent an ablation, which failed to bring me into sinus. Immediately after a second ablation, which also didn’t succeed, I started receiving treatments with the wrist band technology , … despite my skepticism, I am impressed by the fact that, after the very first treatment (in December 2018), I went into sinus, and have remained in sinus ever since (7 months and counting) using the wrist-band technology only…"
D.B. 68, Male, Israel

About Us

CardiaCare was founded in 2015 based on multiple clinical observations with neuromodulation therapy in AFib patients. With technical and clinical proof of concept and secured IP, we are pursuing the relief of one of the most urgent unmet needs in cardiology.

We believe that by using CardiaCare, cardiologists can rapidly improve patient outcomes, reduce atrial fibrillation burden and disease progression and substantially cut hospital financial expenses by reducing Afib related emergency room visits and hospitalizations.

CardiaCare is lead by a team of senior and accomplished Med-tech executives, with a proven track record of several M&A deals with key strategics.

The Team

Management

  • Amos Ziv, CEO

    Expert in integrative cardiovascular support, Former Head of Integrative Medicine Research Unit, Assaf Harofeh Medical Centre.

  • Amalia Herszkowicz, COO

    A seasoned executive with over 20 years’ of management  experience in diverse tech. Extensive experience in regulatory and clinical affairs as well as commercialization.

  • Tsahi Holand, CTO

    Senior engineer with over 10  years R&D experience in major companies, with focus on signal processing and embedded software applications, board & FPGA design

Advisory Board

  • Dr. Irit Yaniv, MD 

    Director, experienced and accomplished senior Medical device industry executive - founder and CEO of several medical device companies. Manageing Partner at Accelmed VC

  • Prof. dr. H.J.G.M. Crijns

    Chair and professor of Cardiology,
    Maastricht University; board member Cardiovascular Research Institute Maastricht - CARIM; chairman Scientific Board Netherlands Heart Foundation.

  • Dr.Roy Beinart, MD

    Electrophysiologist - Department of Cardiology, Head of the Davidoff Arrhythmia Center - Sheba Medical Center, Secretary of The Israeli Association of Electrophysiology.

  • Ron Sacher

    Director, Current CEO of Premia Spine (sold SI Therapies), seasoned medical device executive. Has lead several M&A deals with key strategics   

Contact Us

CardiaCare is an investigational device, which is still being tested and is NOT currently approved or available for sale.